A rare case of COVID-19 pneumonia with severe hyperlipoproteinemia. Issue 4 (19th April 2022)

• Record Type: Journal Article
• Authors: Shimoda, Masafumi; Tanaka, Yoshiaki; Morimoto, Kozo; Kokutou, Hiroyuki; Abe, Taro; Suga, Miyuri; Yoshiyama, Takashi; Yoshimori, Kozo; Ohta, Ken
• Is Part Of: Oxford medical case reports. Volume 2022:Issue 4(2022)
• Publication Date: 2022-04-19
• Subjects: Clinical medicine -- Case studies -- Periodicals; 616.09
• DOI: 10.1093/omcr/omac030
• Languages: English
• ISSNs: 2053-8855

Abstract

Abstract: A 55-year-old woman was admitted to our hospital for coronavirus disease 2019 (COVID-19) pneumonia. Her symptoms improved upon treatment with steroids, remdesivir and heparin. After discharge, she consumed excessive alcohol because of taste disorder due to COVID-19; she also had chylomicronemia with a triglyceride (TG) level of 8750 mg/dl. Chylomicrons and very-low-density lipoprotein were detected by electrophoresis, and she was diagnosed with severe hyperlipoproteinemia, suspected to be Type V hyperlipoproteinemia. She did not have any symptoms of pancreatitis, and her TG levels decreased with fat intake restriction and sobriety. This is a rare case of COVID-19 with hyperlipoproteinemia, and the causes of hyperlipoproteinemia might be associated with COVID-19 complications, steroids and/or lifestyle changes during the pandemic; therefore, changes in TGs should be observed carefully after the resolution of COVID-19.